We are building a strong, well-run business, structured to deliver sustainable results over the long term.
Along with biotechnology leadership, the ARIAD team is focused on its commitment
to deliver long-term value to investors through solid business execution. That means
maintaining disciplined cost control, thoughtful capital deployment and the highest
standards of corporate governance.
Webcast - Replay J.P. Morgan Healthcare Conference 01/14/15 at 3:00 p.m. PT
J.P. Morgan Healthcare Conference Wednesday, January 14, 2015 3:00 p.m. PT